Drug: TYSABRI Injury: Multiple sclerosis Quarter: 2016Q3
Total Records: 77 Number of Pages: 4
| Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
|---|---|---|---|---|---|---|---|---|
| 125982251 | TYSABRI | Multiple sclerosis | BIOGEN | 57.42 YR | F | 0 | 20160726 | US |
| 126005221 | TYSABRI | Multiple sclerosis | BIOGEN | 0.00 | F | 0 | 20160727 | US |
| 126066531 | TYSABRI | Multiple sclerosis | BIOGEN | 0.00 | F | 0 | 20160729 | US |
| 126101751 | TYSABRI | Multiple sclerosis | BIOGEN | 0.00 | F | 0 | 20160801 | US |
| 126102021 | TYSABRI | Multiple sclerosis | BIOGEN | 0.00 | F | 0 | 20160801 | US |
| 126172661 | TYSABRI | Multiple sclerosis | BIOGEN | 0.00 | M | 0 | 20160803 | US |
| 126283811 | TYSABRI | Multiple sclerosis | BIOGEN | 0.00 | F | 0 | 20160808 | US |
| 126354581 | TYSABRI | Multiple sclerosis | BIOGEN | 0.00 | M | 0 | 20160808 | US |
| 126367951 | TYSABRI | Multiple sclerosis | BIOGEN | 0.00 | F | 0 | 20160809 | US |
| 126390272 | TYSABRI | Multiple sclerosis | BIOGEN | 0.00 | F | 0 | 20160829 | US |
| 126393901 | TYSABRI | Multiple sclerosis | BIOGEN | 0.00 | M | 0 | 20160810 | US |
| 126400491 | TYSABRI | Multiple sclerosis | BIOGEN | 0.00 | F | 0 | 20160810 | US |
| 126435381 | TYSABRI | Multiple sclerosis | BIOGEN | 0.00 | F | 0 | 20160811 | US |
| 126436271 | TYSABRI | Multiple sclerosis | BIOGEN | 0.00 | F | 0 | 20160811 | US |
| 126466751 | TYSABRI | Multiple sclerosis | BIOGEN | 0.00 | M | 0 | 20160812 | US |
| 126471411 | TYSABRI | Multiple sclerosis | BIOGEN | 0.00 | F | 0 | 20160812 | US |
| 126510773 | TYSABRI | Multiple sclerosis | BIOGEN | 0.00 | F | 0 | 20160921 | US |
| 126511641 | TYSABRI | Multiple sclerosis | BIOGEN | 21.66 YR | F | 0 | 20160815 | US |
| 126581611 | TYSABRI | Multiple sclerosis | BIOGEN | 0.00 | F | 0 | 20160817 | US |
| 126594542 | TYSABRI | Multiple sclerosis | BIOGEN | 0.00 | F | 0 | 20160923 | US |
Total Records: 77 Number of Pages: 4